This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Nanoparticle Formulation Strategies for Intranasal Drug Delivery
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations
Feasibility of Intranasal Delivery of Thin-Film Freeze-Dried Monoclonal Antibodies
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations
Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies
Webinars, Pharmaceutical, Product Solutions, Device Innovations, Market Insights
